Total Payments
$190,290
2024 Payments
$15,139
Companies
10
Transactions
112
Payment Breakdown by Category
Consulting$107,555 (56.5%)
Travel$52,686 (27.7%)
Other$20,534 (10.8%)
Research$5,500 (2.9%)
Food & Beverage$3,928 (2.1%)
Education$87.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $107,555 | 22 | 56.5% |
| Travel and Lodging | $52,686 | 41 | 27.7% |
| Honoraria | $19,530 | 4 | 10.3% |
| Unspecified | $5,500 | 4 | 2.9% |
| Food and Beverage | $3,928 | 36 | 2.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,003 | 3 | 0.5% |
| Education | $87.00 | 2 | 0.0% |
Payments by Type
General
$184,790
108 transactions
Research
$5,500
4 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alkermes, Inc. | $54,646 | 25 | $0 (2019) |
| Boehringer Ingelheim International GmbH | $50,736 | 16 | $0 (2024) |
| H. Lundbeck A S | $28,791 | 13 | $0 (2022) |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $14,873 | 15 | $0 (2023) |
| Janssen Research & Development, LLC | $8,991 | 9 | $0 (2019) |
| ACADIA Pharmaceuticals Inc | $8,000 | 2 | $0 (2019) |
| Otsuka America Pharmaceutical, Inc. | $7,595 | 15 | $0 (2022) |
| LivaNova USA, Inc. | $7,081 | 6 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $6,239 | 8 | $0 (2024) |
| Alfasigma USA, Inc. | $3,338 | 3 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $15,139 | 13 | Boehringer Ingelheim International GmbH ($8,900) |
| 2023 | $9,891 | 9 | LivaNova USA, Inc. ($7,081) |
| 2022 | $61,172 | 23 | Boehringer Ingelheim International GmbH ($39,526) |
| 2021 | $3,835 | 3 | Otsuka Pharmaceutical Development & Commercialization, Inc. ($2,500) |
| 2020 | $5,753 | 4 | Otsuka Pharmaceutical Development & Commercialization, Inc. ($3,750) |
| 2019 | $46,783 | 17 | Alkermes, Inc. ($24,800) |
| 2018 | $37,485 | 40 | Alkermes, Inc. ($29,846) |
| 2017 | $10,233 | 3 | H. Lundbeck A S ($10,233) |
All Payment Transactions
112 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Boehringer Ingelheim International GmbH | — | Consulting Fee | Cash or cash equivalent | $420.00 | General |
| 07/02/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $4,895.00 | General |
| 07/02/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Travel and Lodging | In-kind items and services | $140.00 | General |
| 07/02/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $35.00 | General |
| 06/07/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Travel and Lodging | In-kind items and services | $171.93 | General |
| 06/04/2024 | Boehringer Ingelheim International GmbH | — | Travel and Lodging | In-kind items and services | $79.84 | General |
| 05/29/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Travel and Lodging | In-kind items and services | $590.52 | General |
| 05/29/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $73.25 | General |
| 05/29/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $20.86 | General |
| 05/24/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Travel and Lodging | In-kind items and services | $312.41 | General |
| 05/22/2024 | Boehringer Ingelheim International GmbH | — | Consulting Fee | Cash or cash equivalent | $1,050.00 | General |
| 05/07/2024 | Boehringer Ingelheim International GmbH | — | Travel and Lodging | In-kind items and services | $4,450.00 | General |
| 05/07/2024 | Boehringer Ingelheim International GmbH | — | Consulting Fee | Cash or cash equivalent | $2,900.00 | General |
| 12/07/2023 | LivaNova USA, Inc. | VNS THERAPY SYMMETRY MODEL 8103 GENERATOR (Device) | Food and Beverage | Cash or cash equivalent | $90.68 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/07/2023 | LivaNova USA, Inc. | VNS THERAPY SYMMETRY MODEL 8103 GENERATOR (Device) | Travel and Lodging | Cash or cash equivalent | $75.18 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/31/2023 | LivaNova USA, Inc. | VNS THERAPY SYMMETRY MODEL 8103 GENERATOR (Device) | Honoraria | Cash or cash equivalent | $5,625.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/20/2023 | LivaNova USA, Inc. | VNS THERAPY SYMMETRY MODEL 8103 GENERATOR (Device) | Food and Beverage | In-kind items and services | $345.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/20/2023 | LivaNova USA, Inc. | VNS THERAPY SYMMETRY MODEL 8103 GENERATOR (Device) | Travel and Lodging | Cash or cash equivalent | $181.26 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/18/2023 | LivaNova USA, Inc. | VNS THERAPY SYMMETRY MODEL 8103 GENERATOR (Device) | Travel and Lodging | Cash or cash equivalent | $764.20 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/26/2023 | Boehringer Ingelheim International GmbH | — | Consulting Fee | Cash or cash equivalent | $420.00 | General |
| 02/14/2023 | Otsuka Pharmaceutical Development & Commercialization, Inc. | — | Consulting Fee | Cash or cash equivalent | $500.00 | General |
| 01/13/2023 | Boehringer Ingelheim International GmbH | — | Consulting Fee | Cash or cash equivalent | $1,890.00 | General |
| 10/18/2022 | Boehringer Ingelheim International GmbH | — | Consulting Fee | Cash or cash equivalent | $5,670.00 | General |
| 10/15/2022 | H. Lundbeck A S | BRINTELLIX (Drug) | Travel and Lodging | Cash or cash equivalent | $6,633.77 | General |
| Category: PSYCHIATRY | ||||||
| 10/15/2022 | H. Lundbeck A S | BRINTELLIX (Drug) | Honoraria | Cash or cash equivalent | $5,172.00 | General |
| Category: PSYCHIATRY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A MULTI-CENTER, RANDOMIZED, CONTROLLED TRIAL TO EVALUATE THE EFFECTIVENESS OF A DIGITAL THERAPEUTIC (CT-152) AS ADJUNCTIVE THERAPY IN ADULT SUBJECTS DIAGNOSED WITH MAJOR DEPRESSIVE DISORDER | Otsuka Pharmaceutical Development & Commercialization, Inc. | $3,000 | 2 |
| A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF BREXPIPRAZOLE AS ADJUNCTIVE THERAPY IN THE MAINTENANCE TREATMENT OF ADULTS WITH MAJOR DEPRESSIVE DISORDER. | Otsuka Pharmaceutical Development & Commercialization, Inc. | $2,500 | 2 |
About Dr. George Papakostas, MD
Dr. George Papakostas, MD is a Psychiatry healthcare provider based in Boston, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/25/2005. The National Provider Identifier (NPI) number assigned to this provider is 1588654131.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. George Papakostas, MD has received a total of $190,290 in payments from pharmaceutical and medical device companies, with $15,139 received in 2024. These payments were reported across 112 transactions from 10 companies. The most common payment nature is "Consulting Fee" ($107,555).
Ad
Practice Information
- Specialty Psychiatry
- Location Boston, MA
- Active Since 10/25/2005
- Last Updated 07/08/2007
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1588654131
Products in Payments
- BRINTELLIX (Drug) $13,506
- REXULTI (Drug) $11,330
- TRINTELLIX (Drug) $10,233
- NUPLAZID (Drug) $8,000
- VNS THERAPY SYMMETRY MODEL 8103 GENERATOR (Device) $7,081
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Boston
Dr. Maurizio Fava, Md, MD
Psychiatry — Payments: $248,730
Psychiatry $248,730
Dr. Robert Birnbaum, Md, Phd, MD, PHD
Psychiatry — Payments: $182,500
Psychiatry $182,500
Dr. Andrew Nierenberg, Md, MD
Psychiatry — Payments: $165,058
Psychiatry $165,058
Dyanna Domilici, M.d, M.D
Psychiatry — Payments: $91,278
Psychiatry $91,278
Dr. Lee Goldstein, M.d., Ph.d, M.D., PH.D
Psychiatry — Payments: $90,000
Psychiatry $90,000
Dr. Gary Sachs, Md, MD
Psychiatry — Payments: $87,949
Psychiatry $87,949